Publications 2013

1. Breth B, Odenbach D, Yemelin A, Schlinck N, Schröder M, Bode M, Antelo L, Andresen K, Thines E, and Foster AJ. The role of the Tra1p transcription factor of Magnaporthe oryzae in spore adhesion and pathogenic development. Fungal Genet Biol., 57: 11-22, 2013

2. Eisel F, Boosen M, Beck M, Heide H, Wittig I, Beck KF, and Pfeilschifter, J.. Platelet-derived growth factor triggers PKA-mediated signalling by a redox-dependent mechanism in rat renal mesangial cells. Biochem Pharmacol., 85(1):101-8, 2013

3. Bachmann M., Ulziibat S., Härdle L., Pfeilschifter J., and Mühl H. IFNa converts IL-22 into a cytokine efficiently activating STAT1 and its downstream targets. Biochem Pharmacol., 85(3): 396-403, 2013

4. Masseli J, Bertog S, Stanczak L, Blankenbach K, Majunke N, Reiffenstein I, Renkhoff K, Lehn K, Wunderlich N, and Sievert H. Transcatheter closure of multiple interatrial communications. Catheter Cardiovasc Interv., 81(5): 825-836, 2013

5. Rose R, Penna-Martinez M, Klahold E, Kärger D, Shoghi F, Kahles H, Bayer M, Hintermann E, Pfeilschifter JM, Badenhoop K, Ramos-Lopez E, and Christen U. Influence of the vitamin D plasma level and vitamin D related genetic polymorphisms on the immune status of patients with type 1 diabetes: A pilot study. Clin Exp Immunol, 171(2): 171-85, 2013

6. Ehser J, Holdener M, Christen S, Bayer M, Pfeilschifter JM, Hintermann E, Bogdanos D, and Christen U. Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis, J Autoimmun 42: 39-49, 2013

7. Christen U and von Herrath M. Virus-induced mouse models for type 1 diabetes. In: Diabetes and Viruses, Springer Verlag, Germany (eds: Keith Taylor, Heikki Hyöty, Antonio Toniolo and Arie Zuckerman), 2013

8. Brauer F, Schmidt K, Zahn RC, Richter C, Radeke HH, Schmitz JE, von Laer D, and Egerer L. A rationally engineered anti-HIV peptide fusion inhibitor with greatly reduced immunogenicity. Antimicrob Agents Chemother., 57(2): 679-88. 2013

9. Schwalm S, Pfeilschifter J, and Huwiler A. Sphingosine-1-phosphate: A Janus-faced mediator of fibrotic diseases. Biochim Biophys Acta, 1831(1): 239-50, 2013

10. Scheiermann P, Bachmann M, Goren I, Zwissler B, Pfeilschifter J, and Mühl H. Application of interleukin-22 mediates protection in experimental acetaminophen-induced acute liver injury. Am J Pathol, 182(4):1107-13, 2013

11. Frey H, Schroeder N, Manon-Jensen T, Iozzo RV, and Schaefer L. Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J, 280: 2165-79, 2013

12. Neill T, Jones HR, Crane-Smith Z, Owens RT, Schaefer L, and Iozzo RV. Decorin evokes rapid secretion of thrombospondin-1 in basal breast carcinoma cells via inhibition of RhoA/ROCK. FEBS J 280: 2353-68, 2013

13. Mühl, H. Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred up by Interferons? Front. Immunol, 2013; 4: 18, doi: 10.3389/fimmu.2013.00018

14. Mühl H, Scheiermann P, Bachmann M, Härdle L, Heinrichs A, and Pfeilschifter J. IL-22 in tissue protective therapy. Br J Pharmacol, 169(4): 761-71. 2013

15. Christen S, Coppieters K, Rose K, Holdener M, Bayer M, Pfeilschifter JM, Hintermann E, von Herrath MG, Aurrand-Lions M, Imhof BA, and Christen U. Blockade but not overexpression of the junctional adhesion molecule C influences virus-induced type 1 diabetes in mice. PLoS One, 8(1):e54675, 2013

16. Doberstein K, Steinmeyer N, Hartmetz AK, Eberhardt W, Mittelbronn M, Harter PN, Juengel E, Blaheta R, Pfeilschifter J, and Gutwein P. MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma Patients. Neoplasia, 15(2): 218-30, 2013

17. Veerkamp J, Rudolph F, Cseresnyes Z, Priller F, Otten C, Renz M, Schaefer L, and Abdelilah-Seyfried S. Unilateral dampening of Bmp activity by Nodal generates cardiac left-right asymmetry. Dev Cell 24: 660-7, 2013

18. Bergis D, Kassis V, Ranglack A, Koeberle V, Piiper A, Kronenberger B, Zeuzem S, Waidmann O, and Radeke HH. High serum levels of the interleukin-33 receptor soluble ST2 as a negative prognostic factor in hepatocellular carcinoma. Transl Oncol,, 6(3): 311-18, 2013

19. Brauer F, Schmidt K, Zahn RC, Richter C, Radeke HH, Schmitz JE, von Laer D, and Egerer L. A rationally engineered anti-HIV peptide fusion inhibitor with greatly reduced immunogenicity. Antimicrob Agents Chemother., 57(2): 679-88, 2013

20. Koch A, Pfeilschifter J, Huwiler A. Sphingosine 1-Phosphate in Renal Diseases. Cell Physiol Biochem. 31(6): 745-60, 2013

21. Meyer zu Heringdorf DM, Ihlefeld K, Pfeilschifter J. Pharmacology of the sphingosine-1-phosphate signalling system. Handb Exp Pharmacol. 215: 239-53, 2013

22. Giegold O, Ogrissek N, Richter C, Schröder M, Herrero San Juan M, Pfeilschifter JM, Radeke HH. CXCL9 causes heterologous desensitization of CXCL12-mediated memory T lymphocyte activation. J. Immunol. 190: 3696-705, 2013

23. Giegold O, Ogrissek N, Radeke HH. Response to comment on „CXCL9 causes heterologous desensitization of CXCL12-mediated memory T lymphocyte activation“. J. Immunol. 191(2): 525-526, 2013

24. Buraschi S, Neill T, Goyal A, Poluzzi C, Smythies J, Owens RT, Schaefer L, Torres A, and Iozzo RV. Decorin causes autophagy in endothelial cells via Peg3. Proc Natl Acad Sci USA 110(28): E2582-91, 2013

25. Coppieters KT, Amirian N, Pagni PP, Baca Jones C, Wiberg A, Lasch S, Hintermann E, Christen U, and von Herrath MG. Functional Redundancy of CXCR3/CXCL10. Signaling in the Recruitment of Diabetogenic Cytotoxic T Lymphocytes to Pancreatic Islets in a Virally Induced Autoimmune Diabetes Model. Diabetes, 62(7): 2492-9, 2013

26. Hintermann E, Ehser J, Bayer M, Pfeilschifter JM, and Christen U. Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6. J. Autoimmun., 44: 49-60, 2013

27. Balah A, Mühl H, Pfeilschifter J, and Akool el-S. Molecular mechanisms of PDGF-AA expression induced by the dsRNA-mimetic poly (I:C) and IL-18. Biochem Biophys Res Commun., 435(4): 691-5, 2013

28. Doller A, Schulz S, Pfeilschifter J, and Eberhardt W. RNA-dependent association with myosin IIA promtes F-actin-guided trafficking of the ELAV-like protein HuR to polysomes. Nucleic Acids Res., 41(19): 9152-9167, 2013

29. Schulz S, Doller A, Pendini NR, Wilce JA, Pfeilschifter J, and Eberhardt W. Domain-specific phosphomimetic mutation allows dissection of different protein kinase C (PKC) isotype-triggered activities of the RNA-binding protein HuR. Cell Signal., 25(12): 2485-2495, 2013

30. Brunkhorst R, Kanaan N, Koch A, Ferreirós N, Mirceska A, Zeiner P, Mittelbronn M, Derouiche A, Steinmetz H, Foerch C, Pfeilschifter J, Pfeilschifter W. FTY720 treatment in the convalescence period improves functional recovery and reduces reactive astrogliosis in photothrombotic stroke. PLoS One 31; 8(7): e70124, 2013

31. Koch A, Völzke A, Puff B, Blankenbach K, Meyer Zu Heringdorf D, Huwiler A, Pfeilschifter J. PPARγ agonists upregulate sphingosine 1-phosphate (S1P) receptor 1 expression, which in turn reduces S1P-induced [Ca2+]i increases in renal mesangial cells. Biochim Biophys Acta, 1831(11): 1634-1643, 2013

32. Babelova A, Jansen F, Sander K, Löhn M, Schaefer L, Rütten H, Stark H, Amann K, Pavenstädt H, Jung O, and Brandes RP. Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease. PLoS One 8(11): e80328, 2013

33. Christen U. The role of autoantibodies in autoimmune hepatitis type 2. Immunotherapy. 5(3): 247-56, 2013

34. Zhu X, Wang Y, Schwiebs A, and Walther T. Chimeric natriuretic peptide ACNP stimulates both natriuretic peptide receptors, the NPRA and NPRB. Mol Cell Endocrinol. 366(1): 117-23, 2013

35. Gäbel K, Schmitt J, Schulz S, Näther DJ, and Soppa J. A Comprehensive Analysis of the Importance of Translation Initiation Factors for Haloferax volcanii Applying Deletion and Conditional Depletion Mutants. PLoS One, 8(11), e77188, 2013

36. Del Galdo S, Vettel C, Meyer zu Heringdorf DM and Wieland T.The activation of RhoC in vascular endothelial cells is required for the S1P receptor type 2-induced inhibition of angiogenesis.Cell Signal. 25(12): 2478-84, 2013

Auf der rechten Seite finden Sie Links zu Publikationen aus den Jahren 2013-2015.

Zur Gesamtübersicht bitte folgenden Link verwenden: Zu den Publikationen
zu Publikationen 2017
zu Publikationen 2016
zu Publikationen 2015
Sekretariat Prof. Dr. Josef Pfeilschifter

Telefon: +49-69-6301-6951
Fax: +49-69-6301-7942/ -7420
Pub Med Online